Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 4;11(19):e026497.
doi: 10.1161/JAHA.122.026497. Epub 2022 Sep 29.

Temporal Trends in Incidence of Premature Cardiovascular Disease Over the Past 7 Decades: The Framingham Heart Study

Affiliations

Temporal Trends in Incidence of Premature Cardiovascular Disease Over the Past 7 Decades: The Framingham Heart Study

Ramachandran S Vasan et al. J Am Heart Assoc. .

Abstract

Background Premature onset of cardiovascular disease (CVD) imposes a significant societal burden and challenges prevention efforts. Methods and Results Trends in the incidence of premature CVD (before age 55, 60, or 65 years, separate analysis for each threshold) were evaluated in 14 464 Framingham Heart Study participants over 7 decades of observation (1950-2019). The change in the incidence of premature CVD (per decade) in men and women was assessed using overdispersed Poisson regression (accounting for cohort effects), adjusting for age at entry and age at onset of premature CVD within each decade. CVD was defined as a composite of fatal or nonfatal coronary heart disease, stroke or transient ischemic attack, peripheral vascular disease, and heart failure. There were 2223 first CVD events (832 in women) before age 65 years during 282 481 person-years of observations (154 587 in women) between 1950 and 2019. The age-adjusted CVD incidence before age 65 years decreased from 14.8 per 1000 person-years (1950-1959) to 4.69 per 1000 person-years (2010-2019) in men and from 7.23 per 1000 person-years (1950-1959) to 1.73 per 1000 person-years (2010-2019) in women. In adjusted analyses, the incidence of premature CVD decreased per decade in men (18.4% [95% CI, 12.0%-24.0%], for onset before age 55 years; 19.5% [95% CI, 12.0%-27.0%], for onset before age 60 years; 21.3% [95% CI, 16.0%-27.0%], for onset before age 65 years) and women (15.1% [95% CI, 7.0%-22.0%], for onset before age 55 years; 14.0% [95% CI, 6.0%-22.0%], for onset before age 60 years; 18.2% [95% CI, 12.0%-24.0%], for onset before age 65 years). The decline in premature CVD was accompanied by a reduction in smoking and increased use of lipid-lowering treatments across the decades. Incidence of premature coronary heart disease decreased, whereas the contribution of stroke to premature CVD burden increased over time. Conclusions The incidence of premature CVD has decreased among White adults in the Framingham cohort over the past 70 years; the residual burden of premature stroke warrants further study. Additional studies of trends in premature CVD in more racially and geographically diverse populations are warranted to elucidate the generalizability of these findings.

Keywords: age of onset; cardiovascular disease; cohort effect; human; incidence; men; women.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Observed and expected premature cardiovascular disease (CVD) incidence rates (y axis) across decades (x axis).
For women and men, this information is presented in green and red, respectively. The symbols represent the observed rates (with ⎕ for Generation 1, ⋄ for Generation 2, and Δ for Generation 3). The rates within a generation over multiple decades are represented by dashed lines (per sex). The solid lines are the expected rates for sex based on the negative binomial model unadjusted for age. A through C, Plots for incidence of CVD before age 55, 60, and 65 years, respectively.

References

    1. Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, Giles WH, Capewell S. Explaining the decrease in US deaths from coronary disease, 1980–2000. N Engl J Med. 2007;356:2388–2398. doi: 10.1056/NEJMsa053935 - DOI - PubMed
    1. Mensah GA, Wei GS, Sorlie PD, Fine LJ, Rosenberg Y, Kaufmann PG, Mussolino ME, Hsu LL, Addou E, Engelgau MM, et al. Decline in cardiovascular mortality. Circ Res. 2017;120:366–380. doi: 10.1161/CIRCRESAHA.116.309115 - DOI - PMC - PubMed
    1. Ritchey MD, Wall HK, Owens PL and Wright JS. Vital signs: state‐level variation in nonfatal and fatal cardiovascular events targeted for prevention by million hearts 2022. MMWR Morb Mortal Wkly Rep 2018;67:974‐982.PMC6132183, DOI: 10.15585/mmwr.mm6735a3. - DOI - PMC - PubMed
    1. Sniderman AD, Thanassoulis G, Williams K, Pencina M. Risk of premature cardiovascular disease vs the number of premature cardiovascular events. JAMA Cardiol. 2016;1:492–494. doi: 10.1001/jamacardio.2016.0991 - DOI - PubMed
    1. Control for Disease Control and Prevention . Vital signs: avoidable deaths from heart disease, stroke, and hypertensive disease‐United States, 2001‐2010. MMWR Morb Mortal Wkly Rep. 2013;62:721–727. - PMC - PubMed

Publication types